Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-01-13Clinical Trial Update: Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomas [Phase 2]
Phase 2 study evaluating cisplatin and irinotecan chemotherapy followed by ZD 1839 (Iressa) in patients with esophageal or gastric carcinoma…
-
CLINICAL_TRIALS trial_result · 2012-01-12Clinical Trial Update: Phase III Trial of DP Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric Cancer [Phase 3]
Phase III trial evaluating DP (docetaxel + cisplatin) followed by FOLFIRI versus the reverse sequence in unresectable gastric cancer has com…
-
CLINICAL_TRIALS trial_result · 2012-01-12Clinical Trial Update: a Prospective Study on the Efficacy of Magnifying Endoscopy With Narrow-band Imaging in Diagnosing Gastric Lesions
A prospective study assessing the diagnostic performance of magnifying endoscopy with narrow-band imaging for gastric lesions has been compl…
-
CLINICAL_TRIALS trial_result · 2012-01-05Clinical Trial Update: S-1 Versus S-1 Plus Cisplatin as an Adjuvant Chemotherapy to Treat Gastric Cancer [Phase 2]
Phase 2 clinical trial update comparing S-1 alone versus S-1 plus cisplatin as adjuvant chemotherapy for gastric cancer.
-
CLINICAL_TRIALS trial_result · 2011-12-30Clinical Trial Update: Confocal Laser Endomicroscopy for in Vivo Molecular Imaging of Gastric Cancer by Targeting MG7-Ag
This update reports on a completed clinical trial evaluating confocal laser endomicroscopy with MG7-Ag targeting for in vivo molecular imagi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-12-28FDA Approved: OXALIPLATIN — Supplemental Application (Winthrop U.S, a business of sanofi-aventis U.S. LLC)
FDA approved a supplemental application for Oxaliplatin, a drug developed by Winthrop U.S, a business of sanofi-aventis U.S. LLC, indicating…
-
CLINICAL_TRIALS trial_result · 2011-12-13Clinical Trial Update: A Study of Oraxol® in Gastric Cancer Patients [Phase 1, Phase 2]
A clinical trial update on Oraxol (oral paclitaxel) for gastric cancer, conducted in Phase 1 and Phase 2, sponsored by Hanmi Pharmaceutical …
-
CLINICAL_TRIALS safety_alert · 2011-12-07Clinical Trial Update: S-1-induced Lacrimal Drainage Obstruction
A clinical trial update notes lacrimal drainage obstruction associated with S-1 in gastric cancer trials. The trial status is currently unkn…
-
CLINICAL_TRIALS trial_result · 2011-11-17Clinical Trial Update: Incidence of Venous Thromboembolism Following Surgery in Patients With Gastric Cancer
This completed clinical trial update reports on the incidence of venous thromboembolism following surgery in patients with gastric cancer.
-
CLINICAL_TRIALS trial_result · 2011-11-10Clinical Trial Update: Taxanes or Platinum in Combination With Capecitabine Followed by Capecitabine Alone as First Line Treatment for Patients With Advanced Adenocarcinoma of Stomach or Esophagogastric Junction [Phase 3]
A Phase 3 clinical trial evaluating taxanes or platinum in combination with capecitabine, followed by capecitabine alone, as first-line trea…
-
CLINICAL_TRIALS trial_result · 2011-11-09Clinical Trial Update: Phase III Randomized Trial of Adjuvant XP Chemotherapy and XP/RT for Resected Gastric Adenocarcinoma [Phase 3]
Phase III randomized trial evaluating XP chemotherapy and XP with radiotherapy after surgical resection for gastric cancer has completed.
-
CLINICAL_TRIALS research · 2011-11-07Clinical Trial Update: Comparison of Billroth-I and Roux-en-Y Reconstruction After Distal Subtotal Gastrectomy [Phase 3]
This is a Phase 3 clinical trial comparing Billroth-I and Roux-en-Y reconstruction after distal subtotal gastrectomy. The current status is …
-
CLINICAL_TRIALS trial_result · 2011-11-04Clinical Trial Update: Safety and Efficacy of Using MASTER to Perform Endoscopic Submucosal Dissection in Human [NA]
This document provides a clinical trial update on the safety and efficacy of using the MASTER technique to perform endoscopic submucosal dis…
-
CLINICAL_TRIALS research · 2011-10-20Clinical Trial Update: Oxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric Cancer [Phase 2]
This clinical trial update describes a Phase 2 study evaluating oxaliplatin with S-1 or with capecitabine in patients with recurrent, metast…
-
CLINICAL_TRIALS trial_result · 2011-10-17Clinical Trial Update: Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluated capecitabine and oxaliplatin with radiotherapy in patients with unresectable gastrointestinal cancers, …
-
CLINICAL_TRIALS trial_result · 2011-10-13Clinical Trial Update: Clinical Outcomes of Endoscopic Resection for Treating WHYX Lesion [Phase 4]
A Phase 4 trial from Samsung Medical Center reports clinical outcomes of endoscopic resection for WHYX lesion associated with extremely well…
-
CLINICAL_TRIALS trial_result · 2011-10-12Clinical Trial Update: Metastatic Gastric Cancer FFCD 03-07 [Phase 3]
Phase 3 trial FFCD 03-07 evaluating metastatic gastric cancer has completed its study.
-
CLINICAL_TRIALS research · 2011-10-06Clinical Trial Update: Effect of Enteral Nutrition Rich in Eicosapentaenoic Acid (EPA) on Patients Receiving Chemotherapy for GI Tumor [Phase 3]
A Phase 3 clinical trial evaluating whether an EPA-rich enteral nutrition improves outcomes in patients receiving chemotherapy for gastric o…
-
CLINICAL_TRIALS trial_result · 2011-10-03Clinical Trial Update: The Effect of Neoadjuvant Chemotherapy on Locally Advanced Gastric Cancer
This document reports on a clinical trial evaluating the effect of neoadjuvant chemotherapy on locally advanced gastric cancer, with the tri…
-
CLINICAL_TRIALS trial_result · 2011-09-05Clinical Trial Update: Study Of Sunitinib In Combination With Cisplatin/Capecitabine Or Oxaliplatin/Capecitabine In Patients With Advanced Gastric Cancer [Phase 1]
Phase 1 study evaluating sunitinib in combination with cisplatin/capecitabine or oxaliplatin/capecitabine in advanced gastric cancer has com…
-
CLINICAL_TRIALS trial_result · 2011-08-16Clinical Trial Update: Comparison of the Analgesic Effect Between Intrathecal Morphine and IV-fentanyl Patient Controlled Analgesia (ITM-IVPCA) and Epidural PCA (PCEA) in Patients Undergoing Gastrectomy -Randomized Allocation Study- [Phase 4]
A Phase IV randomized study comparing analgesic effectiveness of intrathecal morphine with IV fentanyl PCA versus epidural PCA in patients u…
-
CLINICAL_TRIALS trial_result · 2011-08-10Clinical Trial Update: Docetaxel and Oxaliplatin in Gastric Cancer [Phase 2]
Phase 2 clinical trial evaluating docetaxel plus oxaliplatin in gastric cancer has completed, with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-08-05Clinical Trial Update: Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal Cancer [Phase 2]
Phase 2 clinical trial evaluating perioperative chemotherapy with docetaxel, cisplatin, and capecitabine (DCX) for gastric cancer and esopha…
-
CLINICAL_TRIALS trial_result · 2011-08-04Clinical Trial Update: Cancer in Patients With Gabapentin (GPRD)
This clinical trial update reports cancer outcomes in patients treated with gabapentin, with results posted in 2011. It lists several cancer…
-
CLINICAL_TRIALS trial_result · 2011-07-25Clinical Trial Update: S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach [Phase 2]
Phase 2 trial evaluating triacetyluridine in combination with fluorouracil and leucovorin for unresectable, locally advanced, or metastatic …